Member of Lyonbiopole
DicarTech is developing an innovative non-invasive diagnostic medical device for intensive care, pediatry, emergency physicians. DiCART measures the tissue perfusion for patients in severe circulatory failure. Critical situation which, without treatment, can lead to multi-organ failure, lethal situation. DiCART enables reliable, accurate rapid diagnosis to objectively appreciate the efficiency of the therapies involved. Replaces manual and visual assessments, imprecise.
The measure is based on Capillary Refill Time.
A clinical trial on patients has started 09/2022 in Lyon.
Time to market within 9 months.
Strategic application domain: Human Medicine
Application market: Cardiology, Intensive care medicine
Type of activity: Medical device
Technologies: ICT for Health - Digital, Surgical & Medical instruments
Created on jan. 30th, 2018 - 5 employees
Address
28 chem des Pilles 07100 Annonay
Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.